News

Coeptis Therapeutics Holdings, Inc. (Nasdaq; COEP) ("Coeptis" or the "Company"), a biopharmaceutical and technology company focused on developing innovative ...
Azitra Inc., a Branford-based biopharmaceutical firm, said Thursday it has entered into a share purchase agreement with New York-based institutional investor Alumni Capital LP  that it expects will ...
The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid to focus resources on a pair of cancer cell therapies.
CHICAGO — Grove Biopharma has leased space for its headquarters and research and development (R&D) lab at 400 North Aberdeen ...
Shares of Gilead Sciences, Inc. (GILD) traded nearly 3% lower in pre-market on Friday after the company reported ...
Germany's Merck is on the verge of a billion-euro takeover of US biopharmaceutical company Springworks Therapeutics, with the ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
A global biopharma is fighting malaria in endemic countries through partnerships that harness R&D, broaden access to ...
Unfortunately, the same cannot be said for Europe. While it has been home to some of the most important biopharmaceutical companies in the world – many of which have consistently delivered ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
The latest tenant to graduate from the Portal Innovations incubator space in Chicago’s Fulton Market is now leasing 17,000 square feet at 400 North Aberdeen Street.
The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial impact it’ll have for the rest of the year and beyond.